These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21976973)

  • 1. Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells.
    Talaei F; Azizi E; Dinarvand R; Atyabi F
    Int J Nanomedicine; 2011; 6():1963-75. PubMed ID: 21976973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
    Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Al-Husein BA
    Curr Cancer Drug Targets; 2022; 22(2):133-141. PubMed ID: 35081892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nanoparticles for the treatment of human breast cancer.
    Naruphontjirakul P; Viravaidya-Pasuwat K
    Int J Nanomedicine; 2019; 14():4105-4121. PubMed ID: 31239670
    [No Abstract]   [Full Text] [Related]  

  • 4. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
    Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
    J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
    Kefayat A; Vaezifar S
    Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
    Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells.
    Samprasit W; Opanasopit P; Chamsai B
    J Biomed Mater Res B Appl Biomater; 2022 Jun; 110(6):1221-1233. PubMed ID: 34919783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.
    Habibullah MM; Mohan S; Syed NK; Makeen HA; Jamal QMS; Alothaid H; Bantun F; Alhazmi A; Hakamy A; Kaabi YA; Samlan G; Lohani M; Thangavel N; Al-Kasim MA
    Drug Des Devel Ther; 2022; 16():1963-1974. PubMed ID: 35783198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
    Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
    J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of doxorubicin-PLGA loaded chitosan stabilized (Mn, Zn)Fe2O4 nanoparticles: Biological activity and pH-responsive drug release.
    Montha W; Maneeprakorn W; Buatong N; Tang IM; Pon-On W
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():235-240. PubMed ID: 26652369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
    Ye BL; Zheng R; Ruan XJ; Zheng ZH; Cai HJ
    Biochem Biophys Res Commun; 2018 Jan; 495(1):414-420. PubMed ID: 29097204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorin e6 decorated doxorubicin encapsulated chitosan nanoparticles for photo-controlled cancer drug delivery.
    Bhatta A; Krishnamoorthy G; Marimuthu N; Dihingia A; Manna P; Biswal HT; Das M; Krishnamoorthy G
    Int J Biol Macromol; 2019 Sep; 136():951-961. PubMed ID: 31226376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies.
    Helmi O; Elshishiny F; Mamdouh W
    Int J Biol Macromol; 2021 Aug; 184():325-338. PubMed ID: 34119547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
    J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach.
    Kurmi BD; Paliwal R; Paliwal SR
    Int J Biol Macromol; 2020 Dec; 164():2881-2894. PubMed ID: 32853621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-decorated chitosan-iodoacetamide-coated nanocarriers for the potential delivery of doxorubicin to breast cancer cells.
    Myat YY; Sahatsapan N; Rojanarata T; Ngawhirunpat T; Opanasopit P; Pornpitchanarong C; Patrojanasophon P
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128797. PubMed ID: 38104687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
    Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
    Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.